-
Ticker
-
Advertisement
-
-
Dynamic view of the market
U.S. Markets close in 3 hrs, 3 mins
Symbol Value Change Percentage Change DJIA 10,216.21 -10.73 -0.10% NASDAQ 2,146.26 -7.80 -0.36% S&P 500 1,089.99 -3.09 -0.28%
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
-
Stock price
CRGN is not a valid ticker symbol. Please correct your entry or search for the symbol using symbol lookup.
-
Real-Time Headlines
-
Friday, November 6, 2009
-
SEC Filing: Quarterly Financials
11/6/09 | Thomson Financial Wednesday, November 4, 2009
-
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
11/4/09 | PharmaLive -
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
11/4/09 | Business Wire Wednesday, October 21, 2009
-
SEC Filing: Current Event
10/21/09 | Thomson Financial Friday, October 9, 2009
-
A Smaller CuraGen Corp. To Stay Open In Branford
10/9/09 | The Hartford Courant - Hartford CT Tuesday, October 6, 2009
-
SEC Filing: Insider Buy/Sell
Friday, October 2, 2009
-
SEC Filing: Current Event
10/2/09 | Thomson Financial Thursday, October 1, 2009
-
Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
-
Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
10/1/09 | Business Wire Wednesday, September 30, 2009
-
Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
-
Celldex Therapeutics stockholders approve acquisition of CuraGen
9/30/09 | Theflyonthewall.com -
Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
9/30/09 | Business Wire Friday, September 25, 2009
-
SEC Filing: Insider Buy/Sell
Thursday, September 24, 2009
-
CuraGen to host special shareholder meeting
9/24/09 | Theflyonthewall.com Thursday, September 3, 2009
-
SEC Filing: Proxy Statement
9/3/09 | Thomson Financial Friday, August 28, 2009
-
SEC Filing: Proxy Statement
8/28/09 | Thomson Financial Monday, August 17, 2009
-
SEC Filing: Insider Buy/Sell
Monday, August 10, 2009
-
SEC Filing: Insider Buy/Sell
8/10/09 | Thomson Financial Wednesday, August 5, 2009
-
CuraGen Corp. Reports Operating Results (10-Q)
8/5/09 | GuruFocus -
SEC Filing: Quarterly Financials
8/5/09 | Thomson Financial -
Celldex Reports Second Quarter and Six Month 2009 Financial Results
8/5/09 | Genetic Engineering News -
Celldex Reports Second Quarter and Six Month 2009 Financial Results
8/5/09 | Business Wire Friday, July 31, 2009
-
SEC Filing: Proxy Statement
-
CuraGen Reports Second Quarter 2009 Financial Results
-
CuraGen Reports Second Quarter 2009 Financial Results
7/31/09 | PR Newswire Tuesday, July 7, 2009
-
Curagen: Positive Results at ASCO 2009
Monday, June 22, 2009
-
SEC Filing: Acquisition Statement
6/22/09 | Thomson Financial Thursday, June 18, 2009
-
SEC Filing: Current Event
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Wednesday, June 17, 2009
-
CuraGen's (CRGN) CR011-vcMMAE Phase I/II Trial Meets Efficacy Criteria
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
6/17/09 | PR Newswire Tuesday, June 9, 2009
-
SEC Filing: Greater than or Equal to 5% Acquisition
Thursday, June 4, 2009
-
Finkelstein Thompson LLP Announces Investigation of CuraGen Corporation Merger
6/4/09 | GlobeNewswire Wednesday, June 3, 2009
-
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of CuraGen Corporation
6/3/09 | Business Wire -
SEC Filing: Current Event
6/3/09 | Thomson Financial -
Celldex to buy CuraGen for $94.5m
-
Levi & Korsinsky Investigating Breach of Fiduciary Duty by Board of CuraGen (CRGN)
-
CuraGen Updates CR011-vcMMAE Data At ASCO
Tuesday, June 2, 2009
-
Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of CuraGen Corporation
6/2/09 | GlobeNewswire -
At ASCO, CuraGen (CRGN) Updates CR011-vcMMAE Data
Friday, November 6, 2009
-
SEC Filing: Quarterly Financials
11/6/09 | Thomson Financial Wednesday, October 21, 2009
-
SEC Filing: Current Event
10/21/09 | Thomson Financial Tuesday, October 6, 2009
-
SEC Filing: Insider Buy/Sell
Friday, October 2, 2009
-
SEC Filing: Current Event
10/2/09 | Thomson Financial Wednesday, September 30, 2009
-
Celldex Therapeutics stockholders approve acquisition of CuraGen
9/30/09 | Theflyonthewall.com Friday, September 25, 2009
-
SEC Filing: Insider Buy/Sell
Thursday, September 24, 2009
-
CuraGen to host special shareholder meeting
9/24/09 | Theflyonthewall.com Thursday, September 3, 2009
-
SEC Filing: Proxy Statement
9/3/09 | Thomson Financial Friday, August 28, 2009
-
SEC Filing: Proxy Statement
8/28/09 | Thomson Financial Monday, August 17, 2009
-
SEC Filing: Insider Buy/Sell
Monday, August 10, 2009
-
SEC Filing: Insider Buy/Sell
8/10/09 | Thomson Financial Wednesday, August 5, 2009
-
CuraGen Corp. Reports Operating Results (10-Q)
8/5/09 | GuruFocus -
SEC Filing: Quarterly Financials
8/5/09 | Thomson Financial Friday, July 31, 2009
-
SEC Filing: Proxy Statement
Monday, June 22, 2009
-
SEC Filing: Acquisition Statement
6/22/09 | Thomson Financial Thursday, June 18, 2009
-
SEC Filing: Current Event
Tuesday, June 9, 2009
-
SEC Filing: Greater than or Equal to 5% Acquisition
Wednesday, June 3, 2009
-
SEC Filing: Current Event
6/3/09 | Thomson Financial Tuesday, June 2, 2009
-
CuraGen Updates CR011-vcMMAE Data at ASCO
Monday, June 1, 2009
-
Stocks Showing Unusually Heavy Volume - CuraGen Corp, OmniVision Technologies Inc, Coeur d'Alene Mines Corp
6/1/09 | Schaeffer's Investment Research -
BiomedReports: FDA Calendar's Cancer Drug Updates for Allos (NASDAQ:ALTH), Biovest (OTC:BVTI), Celldex (NASDAQ:CLDX) and CuraGen (NASDAQ:CRGN)
6/1/09 | TradingMarkets Friday, May 29, 2009
-
SEC Filing: Proxy Statement
-
xtremepicks.com: CuraGen Corporation (Nasdaq: CRGN) Xtreme picks of the day!
5/29/09 | TradingMarkets -
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
Thursday, May 28, 2009
-
CuraGen to Present CR011-vcMMAE Data at ASCO
Tuesday, May 19, 2009
-
SEC Filing: Proxy Statement
5/19/09 | Thomson Financial Thursday, May 14, 2009
-
4 Biotechs with "Free" Pipelines - Analyst Blog
5/14/09 | Zacks Investment Research -
SEC Filing: Insider Buy/Sell
Thursday, May 7, 2009
-
CuraGen Corp. Reports Operating Results (10-Q)
5/7/09 | GuruFocus -
SEC Filing: Quarterly Financials
5/7/09 | Thomson Financial -
CuraGen Corporation - Financial and Strategic Analysis Review
5/7/09 | TradingMarkets Thursday, April 30, 2009
-
SEC Filing: Annual Financials
4/30/09 | Thomson Financial Thursday, April 23, 2009
-
SEC Filing: Current Event
4/23/09 | Thomson Financial -
CuraGen Reports First Quarter 2009 Financial Results
Tuesday, April 14, 2009
-
Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc., CuraGen Corp., AstraZeneca plc and Micromet Inc. - Press Releases
4/14/09 | Zacks Investment Research -
Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc., CuraGen Corp., AstraZeneca plc and Micromet Inc.
4/14/09 | TradingMarkets Thursday, April 9, 2009
-
CuraGen Caught in the Middle - Analyst Blog
4/9/09 | Zacks Investment Research Monday, March 23, 2009
-
SEC Filing: Insider Buy/Sell
Tuesday, March 10, 2009
-
SEC Filing: Annual Financials
3/10/09 | Thomson Financial Thursday, March 5, 2009
-
SEC Filing: Acquisition Statement
3/5/09 | Thomson Financial
1
<Next>
Wednesday, November 4, 2009
-
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
11/4/09 | PharmaLive Thursday, October 1, 2009
-
Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
Wednesday, September 30, 2009
-
Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
Wednesday, August 5, 2009
-
Celldex Reports Second Quarter and Six Month 2009 Financial Results
8/5/09 | Genetic Engineering News Friday, July 31, 2009
-
CuraGen Reports Second Quarter 2009 Financial Results
Tuesday, July 7, 2009
-
Curagen (NasdaqGM: CRGN)– Positive Results At ASCO 2009
7/7/09 | iStockAnalyst Thursday, June 18, 2009
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Wednesday, June 17, 2009
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Wednesday, June 3, 2009
-
CuraGen Updates CR011-vcMMAE Data At ASCO
Tuesday, June 2, 2009
-
CuraGen Updates CR011-vcMMAE Data at ASCO
Saturday, May 30, 2009
-
CuraGen To Present CR011-vcMMAE Data At ASCO
Friday, May 29, 2009
-
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
Thursday, May 28, 2009
-
CuraGen to Present CR011-vcMMAE Data at ASCO
Thursday, April 23, 2009
-
CuraGen Reports First Quarter 2009 Financial Results
Friday, February 27, 2009
-
CuraGen Announces Board of Director Changes
Tuesday, February 24, 2009
-
Spicing Up The Biotech Portfolio - Curagen and Curis
2/24/09 | iStockAnalyst Thursday, February 19, 2009
-
CuraGen Exploring Strategic Options
2/19/09 | Mergers Unleashed Wednesday, February 18, 2009
-
CuraGen's Board of Directors to Evaluate Strategic Initiatives
Thursday, January 29, 2009
-
CuraGen Corp. (CRGN) reports 4th Quarter ending December 2008 below estimates
Wednesday, November 5, 2008
-
CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference
Tuesday, November 4, 2008
-
CuraGen Announces Preliminary Data From Ongoing Phase II Study Showing Clinical Activity Of CR011-vcMMAE In Patients With Metastatic Melanoma
Monday, November 3, 2008
-
CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
Thursday, October 30, 2008
-
CuraGen Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
10/30/08 | PharmaInfo.net - Canada Wednesday, October 29, 2008
-
CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
Friday, September 26, 2008
-
CuraGen Corporation Receives Notification from NASDAQ
Friday, September 12, 2008
-
CuraGen Completes Enrollment In Phase II Trial Of CR011-vcMMAE In Metastatic Melanoma
9/12/08 | MediLexicon Thursday, September 11, 2008
-
CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Tuesday, July 29, 2008
-
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Thursday, June 26, 2008
-
CuraGen Corporation (CRGN) Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
Thursday, June 12, 2008
-
CuraGen Announces Expansion Of CR011-vcMMAE Phase II Trial In Melanoma
Wednesday, June 11, 2008
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
Tuesday, June 3, 2008
-
CuraGen reports promising results from Phase I/II melanoma study
6/3/08 | Datamonitor Sunday, June 1, 2008
-
CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
Friday, May 30, 2008
-
CuraGen stock back in Nasdaq's good graces
5/30/08 | Mass High Tech Thursday, May 29, 2008
-
CuraGen Corporation Regains NASDAQ Listing Compliance
Monday, May 26, 2008
-
CuraGen sells five million shares of TopoTarget
5/26/08 | Datamonitor Friday, May 23, 2008
-
CuraGen Corporation Sells 5 Million TopoTarget A/S Shares for Approximately $12 Million
Thursday, May 22, 2008
-
CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million
5/22/08 | The Pink Sheet Daily Wednesday, May 14, 2008
-
CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
Wednesday, April 23, 2008
-
CuraGen sells belinostat ownership to TopoTarget
4/23/08 | Datamonitor
1
<Next>
Friday, October 9, 2009
-
A Smaller CuraGen Corp. To Stay Open In Branford
10/9/09 | The Hartford Courant - Hartford CT Wednesday, June 3, 2009
-
Celldex to buy CuraGen for $94.5m
6/3/09 | The Boston Globe - Boston MA Friday, May 29, 2009
-
Cancer Drug-Maker Curagen Agrees To $95 Million Takeover
Thursday, October 11, 2007
-
CuraGen Drug Fails Midstage Study
10/11/07 | Houston Chronicle - Houston TX
1
Wednesday, November 4, 2009
-
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
11/4/09 | Business Wire Thursday, October 1, 2009
-
Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
10/1/09 | Business Wire Wednesday, September 30, 2009
-
Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
9/30/09 | Business Wire Wednesday, August 5, 2009
-
Celldex Reports Second Quarter and Six Month 2009 Financial Results
8/5/09 | Business Wire Friday, July 31, 2009
-
CuraGen Reports Second Quarter 2009 Financial Results
7/31/09 | PR Newswire Wednesday, June 17, 2009
-
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
6/17/09 | PR Newswire Thursday, June 4, 2009
-
Finkelstein Thompson LLP Announces Investigation of CuraGen Corporation Merger
6/4/09 | GlobeNewswire Wednesday, June 3, 2009
-
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of CuraGen Corporation
6/3/09 | Business Wire Tuesday, June 2, 2009
-
Levi & Korsinsky, LLP Investigates Breach of Fiduciary Duty by the Board of CuraGen Corporation
6/2/09 | GlobeNewswire -
CuraGen Updates CR011-vcMMAE Data at ASCO
6/2/09 | PR Newswire Friday, May 29, 2009
-
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
5/29/09 | Business Wire Thursday, May 28, 2009
-
CuraGen to Present CR011-vcMMAE Data at ASCO
5/28/09 | PR Newswire Thursday, April 23, 2009
-
CuraGen Reports First Quarter 2009 Financial Results
4/23/09 | PR Newswire Tuesday, April 14, 2009
-
Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc., CuraGen Corp., AstraZeneca plc and Micromet Inc.
4/14/09 | Business Wire Friday, February 27, 2009
-
CuraGen Announces Board of Director Changes
2/27/09 | PR Newswire Wednesday, February 18, 2009
-
CuraGen's Board of Directors to Evaluate Strategic Initiatives
2/18/09 | PR Newswire Thursday, January 29, 2009
-
CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
1/29/09 | PR Newswire Wednesday, November 5, 2008
-
CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference
11/5/08 | PR Newswire Monday, November 3, 2008
-
CuraGen Reports Third Quarter 2008 Financial Results
11/3/08 | PR Newswire Wednesday, October 29, 2008
-
CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
10/29/08 | PR Newswire Thursday, September 11, 2008
-
CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
9/11/08 | PR Newswire Tuesday, July 29, 2008
-
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
7/29/08 | PR Newswire Tuesday, April 22, 2008
-
CuraGen Reports First Quarter 2008 Financial Results
4/22/08 | PR Newswire -
CuraGen Sells Ownership of Belinostat to TopoTarget A/S
4/22/08 | PR Newswire Wednesday, April 9, 2008
-
CuraGen Advances CR011-vcMMAE into Phase II
4/9/08 | PR Newswire
1
Thursday, October 1, 2009
-
Celldex (CLDX) Closes Acquisition of CuraGen (CRGN)
10/1/09 | StreetInsider.com Tuesday, July 7, 2009
-
Curagen: Positive Results at ASCO 2009
7/7/09 | Seeking Alpha Wednesday, June 17, 2009
-
CuraGen's (CRGN) CR011-vcMMAE Phase I/II Trial Meets Efficacy Criteria
6/17/09 | StreetInsider.com Wednesday, June 3, 2009
-
Levi & Korsinsky Investigating Breach of Fiduciary Duty by Board of CuraGen (CRGN)
6/3/09 | StreetInsider.com Tuesday, June 2, 2009
-
At ASCO, CuraGen (CRGN) Updates CR011-vcMMAE Data
6/2/09 | StreetInsider.com Monday, June 1, 2009